Cipla challenges GSKs Seretide patent in UK
Cipla, the country's second largest drug-meker by marketshare, has challenged a patent of one of Europe's largest pharma companies, GlaxoSmithKline, Plc, on a blockbuster asthma product in the UK .
Cipla, the country's second largest drug-meker by marketshare, has challenged a patent of one of Europe's largest pharma companies, GlaxoSmithKline, Plc, on a blockbuster asthma product in the UK .